First, a Key Correction
Paracetamol (acetaminophen) is NOT an NSAID. This is a very common misconception. It is classified as a non-opioid analgesic and antipyretic, in its own separate drug class. Understanding this distinction is actually central to why it is preferred in many situations.
Paracetamol vs. NSAIDs: What's the Difference?
| Feature | Paracetamol | NSAIDs (e.g., ibuprofen, diclofenac, aspirin) |
|---|
| Class | Non-opioid analgesic/antipyretic | Non-steroidal anti-inflammatory drugs |
| Analgesic | Yes | Yes |
| Antipyretic | Yes | Yes |
| Anti-inflammatory | No (or negligible) | Yes |
| Antiplatelet effect | No | Yes (especially aspirin) |
| COX inhibition site | Primarily central | Peripheral + central |
| GI side effects | Minimal | Significant (ulcers, bleeding) |
| Renal effects | Minimal at therapeutic doses | Can impair renal perfusion |
| Cardiovascular risk | Minimal | Increased (especially COX-2 selective) |
Mechanism of Paracetamol
Paracetamol's mechanism remains incompletely understood but is thought to be primarily central, which explains why it lacks the peripheral anti-inflammatory effects of NSAIDs. Proposed mechanisms include (Clinical Management of Arboviral Diseases, p. 44):
- Inhibition of COX enzymes centrally — produces analgesia and antipyresis without significant peripheral COX inhibition, hence no anti-inflammatory or anticoagulant effects.
- Inhibition of the L-arginine–nitric oxide pathway and reinforcement of descending serotonergic inhibitory pain pathways.
- Effect on cannabinoid receptors via active metabolites (e.g., AM404).
Why Paracetamol is Preferred Over NSAIDs
According to Bailey & Love's Surgery (28th ed., p. 331), paracetamol is the most commonly used drug worldwide and holds Step 1 of the WHO analgesic ladder. Here's why it is preferred:
1. Superior GI Safety
NSAIDs inhibit COX-1, reducing prostaglandin synthesis in the gastric mucosa, leading to gastric ulcers, erosions, and GI bleeding. Paracetamol does not inhibit peripheral COX-1 significantly, so it is safe in patients with peptic ulcer disease or GI sensitivity.
2. No Antiplatelet Effect
NSAIDs (especially aspirin) inhibit thromboxane A2, impairing platelet aggregation. Paracetamol has no clinically significant antiplatelet activity, making it the analgesic of choice:
- Perioperatively (to avoid bleeding)
- In patients on anticoagulants
- In dengue and other thrombocytopenic conditions
3. Safe in Asthma (Usually)
NSAIDs can precipitate aspirin-exacerbated respiratory disease (AERD) by shunting arachidonic acid toward leukotriene synthesis. Paracetamol is generally safe in asthmatic patients.
4. No Renal Impairment at Therapeutic Doses
NSAIDs reduce prostaglandin-mediated renal afferent arteriolar dilation, risking acute kidney injury especially in volume-depleted or elderly patients. Paracetamol at therapeutic doses is renal-safe.
5. No Cardiovascular Risk
NSAIDs (particularly COX-2 selective agents like celecoxib) increase the risk of myocardial infarction and stroke. Paracetamol carries no meaningful cardiovascular risk at therapeutic doses.
6. Safe in Pregnancy
NSAIDs are contraindicated in the third trimester (risk of premature closure of the ductus arteriosus). Paracetamol is the analgesic/antipyretic of choice in pregnancy.
7. Safe Across All Age Groups
Paracetamol is used in neonates, infants, children, adults, and elderly patients. Aspirin is contraindicated in children under 16 (risk of Reye's syndrome).
8. Fewer Drug Interactions
Paracetamol has very few clinically significant drug interactions compared to NSAIDs.
9. Multimodal Analgesia
Its central mechanism complements peripheral-acting drugs. It is a cornerstone of multimodal analgesia protocols in surgical and pain management settings.
When NSAIDs Are Preferred Over Paracetamol
Paracetamol is not always the better choice. NSAIDs are preferred when:
- Inflammation is a primary component (e.g., rheumatoid arthritis, gout, soft tissue injuries)
- Dysmenorrhea (prostaglandin-mediated pain responds well to NSAIDs)
- Renal colic (NSAIDs reduce ureteral spasm via prostaglandin inhibition)
- Dental or musculoskeletal pain with significant inflammatory component
Key Caveat: Paracetamol Overdose
Paracetamol's one major danger is hepatotoxicity in overdose. Its toxic metabolite NAPQI saturates glutathione stores and causes centrilobular liver necrosis. This is the most common cause of acute liver failure in the UK and USA. Therapeutic dosing (max 4 g/day in adults, lower in liver disease or alcoholism) is safe.
Summary: Paracetamol is preferred not because it is "stronger," but because it achieves adequate analgesia and antipyresis with a markedly safer side-effect profile — particularly regarding the GI tract, kidneys, platelets, and cardiovascular system — making it suitable for a far broader patient population.